Junya Yamahana Selected Research

TAK 603

10/2006

TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junya Yamahana Research Topics

Disease

3	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021 - 01/2005
2	Lupus Nephritis 02/2021 - 01/2016
2	Proteinuria 01/2016 - 05/2004
2	Hemolytic-Uremic Syndrome 06/2015 - 12/2012
2	Brain Diseases (Brain Disorder) 06/2015 - 12/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2014 - 06/2013
2	Glomerulonephritis 06/2013 - 10/2006
1	Glaucoma 02/2021
1	Melanoma (Melanoma, Malignant) 02/2021
1	Lymphocele 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016
1	Anemia 01/2016
1	Ascites 01/2016
1	Central Nervous System Diseases (CNS Diseases) 06/2015
1	Blister (Bulla) 04/2014
1	Bullous Pemphigoid (Pemphigoid) 04/2014
1	Eosinophilia 04/2014
1	Wilms Tumor (Wilm's Tumor) 06/2013
1	Infections 12/2012
1	Colitis 12/2012
1	Necrosis 12/2012
1	Hypoparathyroidism 01/2007
1	Bone Diseases (Bone Disease) 01/2007
1	Diabetes Mellitus 01/2007
1	Body Weight (Weight, Body) 10/2006
1	Inflammation (Inflammations) 09/2006
1	Reperfusion Injury 09/2006
1	Hydrocephalus (Hydrocephaly) 05/2004
1	Nephritis 05/2004
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 05/2004
1	Brain Abscess (Abscess, Brain) 05/2004

Drug/Important Bio-Agent (IBA)

2	AutoantibodiesIBA 01/2016 - 05/2004
2	CytokinesIBA 06/2015 - 12/2012
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2013 - 05/2004
2	InterleukinsIBA 12/2012 - 09/2006
1	LysophospholipidsIBA 02/2021
1	Phospholipases A1 (Phospholipase A1)IBA 02/2021
1	PhosphatidylserinesIBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	AntibodiesIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016
1	EnzymesIBA 06/2015
1	ImmunosorbentsIBA 06/2015
1	tau Proteins (tau Protein)IBA 06/2015
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 04/2014
1	Polymethyl Methacrylate (Sol)IBA 04/2014
1	CelluloseIBA 04/2014
1	cellulose triacetateIBA 04/2014
1	Keratins (Keratin)IBA 06/2013
1	NeopterinIBA 12/2012
1	Interleukin-8 (Interleukin 8)IBA 12/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2012
1	Therapeutic UsesIBA 01/2007
1	Parathyroid Hormone (Parathormone)IBA 01/2007
1	Phosphates (Orthophosphate)IBA 01/2007
1	Calcium Carbonate (Limestone)FDA Link 01/2007
1	Vitamin D FDA LinkGeneric 01/2007
1	Sevelamer (RenaGel)FDA Link 01/2007
1	CalciumIBA 01/2007
1	TAK 603IBA 10/2006
1	A-factor (Streptomyces)IBA 09/2006
1	ChemokinesIBA 09/2006
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2005
1	N 30IBA 01/2005
1	Mitogen-Activated Protein KinasesIBA 01/2005
1	Complement System Proteins (Complement)IBA 05/2004
1	CreatinineIBA 05/2004
1	Myeloblastin (Proteinase 3)IBA 05/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2004
1	SteroidsIBA 05/2004

Therapy/Procedure

2	Therapeutics 01/2016 - 05/2004
2	Renal Dialysis (Hemodialysis) 04/2014 - 01/2007
1	Kidney Transplantation 01/2016
1	Ventriculoperitoneal Shunt 05/2004